The time interval between the start of anti-leprosy treatment and the development of reactions in borderline patients.
D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000276:immunology; D013997:Time Factors
D003622:Dapsone